Marilena Vrana: Building a Resilient Plasma Ecosystem in Europe
Marilena Vrana, Vice President at the Plasma Protein Therapeutics Association (PPTA) Europe, shared a post on LinkedIn:
“Four years at PPTA Europe, and the starting point has not changed: plasma-derived medicines (PDMPs) are a connection between people.
They begin with one person taking the time to donate for the benefit of another.
I spent my 4th year anniversary in Berlin with PPTA Germany for a constructive meeting on the legislative changes that affect everything from collection to patient access.
Europe has a solid ecosystem for plasma and PDMPs: diversity in collectors: public, private and non-profit, and several manufacturers with continued investment across the value chain. Its legislative framework should build on that strength.
A resilient European plasma ecosystem is not a nice-to-have. It is part of a healthcare system that cares for everyone who needs plasma-derived medicines.”
Other posts featuring Marilena Vrana on Hemostasis Today.
-
Nov 16, 2026, 10:24Hichem Selatna: Advancing Hematology Laboratory Automation
-
Nov 16, 2026, 10:20Erin Harris: CRISPR Gene Therapy in Children
-
Nov 16, 2026, 10:19Beverley Hunt: PE Knows No Age – Isaac’s Story
-
Nov 16, 2026, 10:08Abdul Mannan: When Normal Blood Counts Hide Iron Deficiency
-
Nov 16, 2026, 09:47Ankit Kumar: A Memorable Experience at Haematocon 2026
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations